CN116171333A - 用于检测严重急性呼吸综合征冠状病毒2(sars-cov-2)、甲型流感和乙型流感的组合物和方法 - Google Patents

用于检测严重急性呼吸综合征冠状病毒2(sars-cov-2)、甲型流感和乙型流感的组合物和方法 Download PDF

Info

Publication number
CN116171333A
CN116171333A CN202180020097.0A CN202180020097A CN116171333A CN 116171333 A CN116171333 A CN 116171333A CN 202180020097 A CN202180020097 A CN 202180020097A CN 116171333 A CN116171333 A CN 116171333A
Authority
CN
China
Prior art keywords
seq
primer
oligonucleotide sequence
cov
sars
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202180020097.0A
Other languages
English (en)
Chinese (zh)
Inventor
M·R·丰特查
M·黑尔
K·曼吉普迪
C·马诺哈尔
R·S·拉维拉拉
C·D·桑蒂尼
E·斯皮尔
J·孙
T·谭
H·张
M·E·易
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of CN116171333A publication Critical patent/CN116171333A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6816—Hybridisation assays characterised by the detection means
    • C12Q1/6818—Hybridisation assays characterised by the detection means involving interaction of two or more labels, e.g. resonant energy transfer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/686—Polymerase chain reaction [PCR]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2537/00—Reactions characterised by the reaction format or use of a specific feature
    • C12Q2537/10—Reactions characterised by the reaction format or use of a specific feature the purpose or use of
    • C12Q2537/143—Multiplexing, i.e. use of multiple primers or probes in a single reaction, usually for simultaneously analyse of multiple analysis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2563/00—Nucleic acid detection characterized by the use of physical, structural and functional properties
    • C12Q2563/107—Nucleic acid detection characterized by the use of physical, structural and functional properties fluorescence
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/16—Primer sets for multiplex assays

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
CN202180020097.0A 2020-03-09 2021-03-08 用于检测严重急性呼吸综合征冠状病毒2(sars-cov-2)、甲型流感和乙型流感的组合物和方法 Pending CN116171333A (zh)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US202062987066P 2020-03-09 2020-03-09
US62/987066 2020-03-09
US202063075579P 2020-09-08 2020-09-08
US63/075579 2020-09-08
US202063122869P 2020-12-08 2020-12-08
US63/122869 2020-12-08
PCT/EP2021/055748 WO2021180631A1 (en) 2020-03-09 2021-03-08 Compositions and methods for detecting severe acute respiratory syndrome coronavirus 2 (sars-cov-2), influenza a and influenza b

Publications (1)

Publication Number Publication Date
CN116171333A true CN116171333A (zh) 2023-05-26

Family

ID=74867541

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202180020097.0A Pending CN116171333A (zh) 2020-03-09 2021-03-08 用于检测严重急性呼吸综合征冠状病毒2(sars-cov-2)、甲型流感和乙型流感的组合物和方法

Country Status (7)

Country Link
US (2) US12195811B2 (cg-RX-API-DMAC7.html)
EP (1) EP4118239A1 (cg-RX-API-DMAC7.html)
JP (1) JP7796660B2 (cg-RX-API-DMAC7.html)
KR (1) KR102938730B1 (cg-RX-API-DMAC7.html)
CN (1) CN116171333A (cg-RX-API-DMAC7.html)
CA (1) CA3166337A1 (cg-RX-API-DMAC7.html)
WO (1) WO2021180631A1 (cg-RX-API-DMAC7.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7796660B2 (ja) * 2020-03-09 2026-01-09 エフ. ホフマン-ラ ロシュ アーゲー 重症急性呼吸器症候群コロナウイルス2(sars-cov-2)、インフルエンザa及びインフルエンザbを検出するための組成物及び方法
JP7839740B6 (ja) * 2020-03-31 2026-04-24 アンビエント バイオサイエンシズ インコーポレーテッド 生体試料中の標的分析物の迅速な検出のための装置および方法
KR20220164745A (ko) * 2020-04-06 2022-12-13 옥탄트, 인크. 병원체 진단 시험
US20220042117A1 (en) * 2020-08-06 2022-02-10 Roche Molecular Systems, Inc. COMPOSITIONS AND METHODS FOR THE SIMULTANEOUS DETECTION OF INFLUENZA A, INFLUENZA B, AND SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-CoV-2)
CN113801963B (zh) * 2021-09-17 2024-03-26 佛山科学技术学院 一种检测冠状病毒的引物探针组合、试剂盒及方法
JP7825255B2 (ja) * 2021-09-22 2026-03-06 学校法人 名城大学 標的配列の検出方法及び標的配列の検出装置
CN114350849A (zh) * 2021-12-21 2022-04-15 圣湘生物科技股份有限公司 检测SARS-CoV-2的组合物、试剂盒、方法及其用途
CN114561495A (zh) * 2022-04-28 2022-05-31 广东国盛医学科技有限公司 核酸组合及其应用、病毒检测试剂盒和检测病毒的方法
CN114622042B (zh) * 2022-05-17 2022-08-19 北京肝病研究所 检测新型冠状病毒联合呼吸道病毒的引物探针组和检测试剂盒
CN121406831B (zh) * 2025-12-26 2026-05-15 圣湘生物科技股份有限公司 鉴别呼吸道病原体的核酸组合产品、pcr预混物、试剂盒及方法

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU596068B2 (en) 1983-02-22 1990-04-26 Syngene, Inc. Defined sequence single strand oligonucleotides incorporating reporter groups, process for the chemical synthesis thereof, and nucleosides useful in such synthesis
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4965188A (en) 1986-08-22 1990-10-23 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4996143A (en) 1985-12-23 1991-02-26 Syngene, Inc. Fluorescent stokes shift probes for polynucleotide hybridization
US4800159A (en) 1986-02-07 1989-01-24 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences
US5703055A (en) 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
US5683896A (en) 1989-06-01 1997-11-04 Life Technologies, Inc. Process for controlling contamination of nucleic acid amplification reactions
US5035996A (en) 1989-06-01 1991-07-30 Life Technologies, Inc. Process for controlling contamination of nucleic acid amplification reactions
US5210015A (en) 1990-08-06 1993-05-11 Hoffman-La Roche Inc. Homogeneous assay system using the nuclease activity of a nucleic acid polymerase
US5994056A (en) 1991-05-02 1999-11-30 Roche Molecular Systems, Inc. Homogeneous methods for nucleic acid amplification and detection
EP1067134B1 (en) 1991-11-07 2004-07-28 Nanotronics, Inc. Hybridization of polynucleotides conjugated with chromophores and fluorophores to generate donor-to-donor energy transfer system
EP1442794B1 (en) 1996-06-04 2006-03-29 University Of Utah Research Foundation System and method for carrying out and monitoring biological processes
DE69739357D1 (de) 1996-06-04 2009-05-28 Univ Utah Res Found Überwachung der hybridisierung während pcr
DK0866071T3 (da) 1997-03-20 2005-01-17 Hoffmann La Roche Modificerede primere
US7339051B2 (en) 2003-04-28 2008-03-04 Isis Pharmaceuticals, Inc. Compositions and methods for the treatment of severe acute respiratory syndrome (SARS)
AU2003254594A1 (en) * 2003-07-14 2005-01-28 Capital Biochip Company, Ltd. Methods and compositions for detecting sars virus and other infectious agents
EP2361974A1 (fr) 2003-12-02 2011-08-31 Institut Pasteur Utilisation des proteines et des peptides codés par le genome d'une nouvelle souche de coronavirus associé au SRAS
CA2624917C (en) 2005-10-05 2013-07-09 F. Hoffmann-La Roche Ag Non-fluorescent energy transfer
JP7796660B2 (ja) * 2020-03-09 2026-01-09 エフ. ホフマン-ラ ロシュ アーゲー 重症急性呼吸器症候群コロナウイルス2(sars-cov-2)、インフルエンザa及びインフルエンザbを検出するための組成物及び方法
US20210293815A1 (en) * 2020-03-17 2021-09-23 Detect, Inc. Self- administrable diagnostic test with integrated swab
US20220364157A1 (en) * 2020-03-27 2022-11-17 Pathogendx, Inc. Methods for Detecting Low Levels of Covid-19 Virus
US11308612B2 (en) * 2020-04-17 2022-04-19 Qure.Ai Technologies Private Limited Systems and methods for detection of infectious respiratory diseases
BR112022026414A2 (pt) * 2020-06-26 2023-03-14 Cepheid Métodos para detectar sars-cov-2, influenza e rsv
WO2022050141A1 (ja) * 2020-09-04 2022-03-10 東洋紡株式会社 マルチプレックスpcrによる呼吸器感染症の検査方法

Also Published As

Publication number Publication date
EP4118239A1 (en) 2023-01-18
CA3166337A1 (en) 2021-09-16
JP7796660B2 (ja) 2026-01-09
WO2021180631A1 (en) 2021-09-16
US12195811B2 (en) 2025-01-14
US20250171862A1 (en) 2025-05-29
KR102938730B1 (ko) 2026-03-12
KR20220152205A (ko) 2022-11-15
US20210285061A1 (en) 2021-09-16
JP2023516472A (ja) 2023-04-19

Similar Documents

Publication Publication Date Title
KR102938730B1 (ko) 중증 급성 호흡기 증후군 코로나바이러스 2(sars-cov-2), 인플루엔자 a 및 인플루엔자 b를 검출하기 위한 조성물 및 방법
CN110651051B (zh) 用于检测巴贝虫的组合物和方法
AU2021294330A1 (en) Methods of detecting SARS-CoV-2, influenza, and RSV
US20220042117A1 (en) COMPOSITIONS AND METHODS FOR THE SIMULTANEOUS DETECTION OF INFLUENZA A, INFLUENZA B, AND SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-CoV-2)
EP3891302B1 (en) Compositions and methods for detection of candida auris
JP7105553B2 (ja) ターゲット核酸検出のための二重プローブアッセイ
US20220290221A1 (en) Compositions and methods for detecting severe acute respiratory syndrome coronavirus 2 (sars-cov-2) variants having spike protein mutations
JP6117775B2 (ja) スタフィロコッカス・アウレウスの検出のための組成物及び方法
US20240240273A1 (en) Compositions and Methods for Detecting Hepatitis Delta Virus by a Dual-Target Assay
EP4004240B1 (en) Compositions and methods for detection of epstein barr virus (ebv)
US20180080091A1 (en) Detection of influenza b viruses
US20260055475A1 (en) Compositions and methods for detecting monkeypox virus
CN120418449A (zh) 用于检测耐碳青霉烯的醋酸钙不动杆菌-鲍氏不动杆菌(crab)的组合物和方法
US20240124946A1 (en) Compositions and methods for detection of human parainfluenza viruses 1-4 (hpiv 1-4)
CN117441029A (zh) 用于检测具有刺突蛋白突变的严重急性呼吸综合征冠状病毒2(sars-cov-2)变体的组合物和方法
JP2019524123A (ja) 核酸の増幅及び検出/定量の効率を改良するためのヘルパーオリゴヌクレオチド
EP3332026B1 (en) Compositions and methods for detection of mycobacterium tuberculosis

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination